These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2408819)

  • 1. Removal of hormones by hemofiltration and hemodialysis with a highly permeable polysulfone membrane.
    Wizemann V; Velcovsky HG; Bleyl H; Brüning S; Schütterle G
    Contrib Nephrol; 1985; 46():61-8. PubMed ID: 2408819
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hemodialysis membrane type on parathyroid hormone removal.
    Kudlac H; Fielding AM; Williams AJ
    Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
    Ljungberg B; Jacobson SH; Lins LE; Pejler G
    Clin Nephrol; 1992 Aug; 38(2):97-100. PubMed ID: 1325310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodiafiltration using a polysulfone membrane, its ultrafiltration characteristics and biocompatibility].
    Iarmolinskiĭ IS; Stetsiuk EA; Iarmagomedov AA
    Urol Nefrol (Mosk); 1987; (2):45-9. PubMed ID: 3590419
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year follow-up of short dialysis with a membrane highly permeable to middle molecules.
    Man NK; Granger A; Rondon-Nucete M; Zingraff J; Jungers P; Sausse A; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1973; 10(0):236-46. PubMed ID: 4802554
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of a polysulfone membrane. A new perspective in dialysis?
    Streicher E; Schneider H
    Contrib Nephrol; 1985; 46():1-13. PubMed ID: 4006470
    [No Abstract]   [Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
    Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
    Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy.
    Floris M; Marchionna N; Clementi A; Kim JC; Cruz DN; Nalesso F; Zanella M; Garzotto F; de Cal M; Virzì GM; Brendolan A; Ronco C
    Blood Purif; 2011; 32(2):133-8. PubMed ID: 21654165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine clearance by high-flux polysulfone dialyzers.
    Ben-Chetrit E; Backenroth R; Levy M
    Arthritis Rheum; 1998 Apr; 41(4):749-50. PubMed ID: 9550491
    [No Abstract]   [Full Text] [Related]  

  • 15. No evidence for endotoxin transfer across high flux polysulfone membranes.
    Bommer J; Becker KP; Urbaschek R; Ritz E; Urbaschek B
    Clin Nephrol; 1987 Jun; 27(6):278-82. PubMed ID: 3608251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
    Ouseph R; Hutchison CA; Ward RA
    Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability for middle and higher molecular weight substances. Comparison between polysulfone and cuprophan dialyzers.
    Brunner H; Mann H; Stiller S; Sieberth HG
    Contrib Nephrol; 1985; 46():33-42. PubMed ID: 4006479
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficiency in hemodialysis with polyethersulfone membrane (DIAPES).
    Locatelli F; Di Filippo S; Manzoni C
    Contrib Nephrol; 2003; (138):55-8. PubMed ID: 12463146
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.